Post GMO era: EU faces defining moment in regulating gene editing

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Last month, a non-browning button mushroom became the first CRISPR-edited organism to get a green light from the U.S. government – and several crops developed with two older, less efficient editing tools have already been waved through.

But whether such products will ever arrive on European farms is another matter, since the European Commission has so far not made a decision on how they will be regulated, leaving the new science in limbo.

Greenpeace wants the EU’s GMO law to be fully applied to “new breeding techniques” (NBT) like gene editing, because of potential environmental and health impacts, and it fears Brussels is dithering under pressure from Washington.


Biotechnology companies, meanwhile, argue their gene-edited products are “non-GMO”, since they do not contain foreign DNA from a different species.

Related article:  How Bangladesh emerged as world innovator in pest-resistant, nutritionally fortified GM crops

Read full, original post: From hardy pigs to super-crops, gene editing poses new EU dilemma

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend